Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05081180
Title Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications

diffuse midline glioma, H3 K27M-mutant

central nervous system cancer

Therapies

Avelumab + Lenvatinib

Age Groups: adult | child
Covered Countries USA | FRA | DEU | CAN


No variant requirements are available.